Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Montero

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Clinical and Translational Medicine|February 16, 2024
Tolerating CD47Jeffrey S Isenberg, Enrique Montero
Cells|January 9, 2026
If Plan A Does Not Work: The CD47 Ectodomain as a Target for Immune ToleranceEnrique Montero, Jeffrey S Isenberg
Cancer Immunology, Immunotherapy : CII|May 22, 2023
The TSP1-CD47-SIRPα interactome: an immune triangle for the checkpoint eraEnrique Montero, Jeffrey S Isenberg
Current Opinion in Endocrinology, Diabetes, and Obesity|June 29, 2021
Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetesNeslihan Erdem, Enrique Montero, Bart O Roep
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 12, 2009
Interferon-alpha conditioned sensitivity to an anti-epidermal growth factor receptor monoclonal antibody in a human lung cancer cell line with intermediate expression of the receptorArlhee Diaz, Ana E Batista, Enrique Montero
Annals of the New York Academy of Sciences|September 7, 2007
Interleukin-2 mastering regulation in cancer and autoimmunityEnrique Montero, Livan Alonso, Rolando Perez, et al.
Iscience|June 16, 2025
Agricultural plastics as marine pollutants: Empirical evidence from inland and coastal field surveysCarmen Morales-Caselles, Josué Viejo, Enrique Montero, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Epidermal growth factor receptor modulates the tumorigenic potential of melanomaArlhee Diaz, Eduardo Suarez, Rances Blanco, et al.
Clinical Immunology (Orlando, Fla.)|November 12, 2013
Combination therapy with anti-CD6 and oral insulin immunization reverses recent onset diabetes in non obese diabetic mice but fails to induce lasting toleranceDarius A Schneider, Ghanashyam Sarikonda, Enrique Montero, et al.
Cancer Biology & Therapy|July 22, 2010
Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFRChetana Basavaraj, Patricia Sierra, Jatteppanavar Shivu, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Clinical and Translational Medicine|February 16, 2024
Tolerating CD47Jeffrey S Isenberg, Enrique Montero
Cells|January 9, 2026
If Plan A Does Not Work: The CD47 Ectodomain as a Target for Immune ToleranceEnrique Montero, Jeffrey S Isenberg
Cancer Immunology, Immunotherapy : CII|May 22, 2023
The TSP1-CD47-SIRPα interactome: an immune triangle for the checkpoint eraEnrique Montero, Jeffrey S Isenberg
Current Opinion in Endocrinology, Diabetes, and Obesity|June 29, 2021
Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetesNeslihan Erdem, Enrique Montero, Bart O Roep
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 12, 2009
Interferon-alpha conditioned sensitivity to an anti-epidermal growth factor receptor monoclonal antibody in a human lung cancer cell line with intermediate expression of the receptorArlhee Diaz, Ana E Batista, Enrique Montero
Annals of the New York Academy of Sciences|September 7, 2007
Interleukin-2 mastering regulation in cancer and autoimmunityEnrique Montero, Livan Alonso, Rolando Perez, et al.
Iscience|June 16, 2025
Agricultural plastics as marine pollutants: Empirical evidence from inland and coastal field surveysCarmen Morales-Caselles, Josué Viejo, Enrique Montero, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Epidermal growth factor receptor modulates the tumorigenic potential of melanomaArlhee Diaz, Eduardo Suarez, Rances Blanco, et al.
Clinical Immunology (Orlando, Fla.)|November 12, 2013
Combination therapy with anti-CD6 and oral insulin immunization reverses recent onset diabetes in non obese diabetic mice but fails to induce lasting toleranceDarius A Schneider, Ghanashyam Sarikonda, Enrique Montero, et al.
Cancer Biology & Therapy|July 22, 2010
Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFRChetana Basavaraj, Patricia Sierra, Jatteppanavar Shivu, et al.
Pageof 6